Prostate Cancer Channel

Prostate Cancer Channel

Brought to you by Oncology Times

A collection of timely studies, news, treatment options and more is presented in this concise, invaluable resource.

Resource Library

 

Find the latest in prostate cancer research and developments in this continually updated collection of articles.  

More

 

Experts share insights into prostate cancer trends, progress, and breakthroughs. 

More

 

Exclusive commentary on prostate cancer is presented by leaders in the industry.

More

 

Download the Understanding Prostate Cancer anatomical chart.

More

FDA Approves Enzalutamide for Non-Metastatic Castration-Resistant Prostate Cancer

The FDA approved a supplemental New Drug Application (sNDA) for enzalutamide, following FDA Priority Review designation, based on results from the phase III PROSPER trial. The FDA action broadens the indication for enzalutamide to men with castration-resistant prostate cancer (CRPC), now including men with non-metastatic CRPC.

Read More

Loading